
While the findings indicated no need for a new vaccine to tackle the new strains, Pfizer and BioNTech said they would respond if there was evidence that the variants could defeat their current vaccine.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3r38CHd
via
IFTTT
0 comments:
Post a Comment